| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 108,270 | 97,622 | 93,699 | 141,777 | | Cost of Revenue | (139,179) | 69,093 | 83,898 | 105,619 | | | Gross Profit | 247,449 | 28,529 | 9,801 | 36,158 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 240,733 | 28,005 | 28,819 | 31,022 | | Non Recurring |
-
| 12,077 | 13,362 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,716 | (11,553) | (32,380) | 5,136 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (378) | (3,359) | (237) | 2,123 | | Earnings Before Interest And Taxes | 7,250 | (14,912) | (32,617) | 7,259 | | Interest Expense |
-
|
-
|
-
| (72) | | Income Before Tax | 7,250 | (14,912) | (32,617) | 7,331 | | Income Tax Expense | 2,842 | 855 | (13,690) | 2,048 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,408 | (15,767) | (18,927) | 5,283 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,408 | (15,767) | (18,927) | 5,283 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,408 | ($15,767) | ($18,927) | $5,283 |
|
0.29% Nasdaq 
Income Statement
